The Middle East life sciences market will grow to $36bn by 2028, driven by R&D investments, digital health adoption, and pharmaceutical manufacturing expansion
pharma tech
Latest in pharma tech
ajit joshi
Dubai’s Shuaa invests in Swiss pharma-tech supply chain firm
Shuaa Capital chief says SkyCell is a ‘great fit’ for investment criteria